Loading clinical trials...
Loading clinical trials...
Randomized Phase II Study of Checkpoint Blockade Immunotherapy Combined With Stereotactic Body Radiation Therapy in Advanced Metastatic Disease
Conditions
Interventions
Checkpoint blockade immunotherapy
Checkpoint blockade immunotherapy plus SBRT
Locations
1
United States
UCSD Moores Cancer Center
La Jolla, California, United States
Start Date
September 2, 2016
Primary Completion Date
August 16, 2021
Completion Date
August 15, 2024
Last Updated
September 30, 2025
NCT04657068
NCT04585750
NCT07197671
NCT05831579
NCT04900818
NCT07269080
Lead Sponsor
University of California, San Diego
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions